Clinical significance of the cellular pharmacodynamics of tacrolimus in living-donor liver transplantation

Cell Transplantation

Volumn 18, Issue 5-6, 2009, Pages 657-664

  Mijiti, Abuduxukuer ^a,b   Matsuno, Naoto ^a   Takeuchi, Hironori ^c   Unezaki, Sakae ^c   Nagao, Takeshi ^a   Hirano, Toshihiko ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Kashgar First People's Hospital   (China)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Allograft rejection; Infection; Living donor liver transplantation; Peripheral blood mononuclear cells; Tacrolimus

Indexed keywords

CONCANAVALIN A; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE PROLIFERATION; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL;

EID: 70349241612     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970901805-622     Document Type: Article

References (31)

1. Aoki, C. A.; Roifman, C. M.; Lian, Z. X.; Bowlus, C. L.; Norman, G. L.; Shoenfeld, Y.; Mackay, I. R.; Gershwin, M. E. Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: A main role for MHC-unrestricted T cells. Arch. Immunol. Ther. Exp. (Warsz) 50:307-316; 2000.
2. Aoki, C. A.; Roifman, C. M.; Lian, Z. X.; Bowlus, C. L.; Norman, G. L.; Shoenfeld, Y.; Mackay, I. R.; Gershwin, M. E. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J. Autoimmun. 27:50-53; 2006.
3. Bouma, G. J.; Hollander, D. A.; van der Meer-Prins, E. M.; van Bree, S. P.; van Rood, J. J.; van der Woude, F. J.; Claas, F. H. In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation 62:1422-1429; 1996.
4. Briggs, W. A.; Gimenez, L. F.; Samaniego-Picota, M.; Choi, M. J.; Nadasdy, T.; Eustace, J. Relationship between syslymphocyte and clinical steroid responsiveness in focal segmental glomerulosclerosis. J. Clin. Pharmacol. 40: 115-123; 2000.
5. Dudley, J.; Truman, C.; McGraw, M.; Tizard, J.; Haque, G.; Bradley, B. Estimation of individual sensitivity to cyclosporin in children awaiting renal transplantation. Nephrol. Dial. Transplant. 18:403-410; 2003.
6. Fiuza, C.; Salcedo, M.; Clemente, G.; Tellado, J. M. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J. Infect. Dis. 182:526-533; 2000.
7. Francis, D. M.; Dumble, L. J.; Bowes, L.; Clunie, G. J.; Macdonald, I. M. Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. Transplantation 46:853-857; 1988.
8. Gopalswamy, N.; Mehta, V.; Barde, C. J. Risks of intra-abdominal nonshunt surgery in cirrhotics. Dig. Dis. 16: 225-231; 1998.
9. Gremion, C.; Cerny, A. Hepatitis C virus and the immune system: A concise review. Rev. Med. Virol. 15:235-268; 2005.
10. Haycock, K. A.; Roth, R.; Gagnon, J. Statview. Berkeley, CA: Abacus Concepts; 1994.
11. Hearing, S. D.; Norman, M.; Probert, C. S.; Haslam, N.; Dayan, C. M. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45: 382-388;1999.
12. Hirano, T. Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine. Int. Immuno-pharmacol. 7:3-22; 2007.
13. Hirano, T.; Akashi, T.; Keira, T.; Oka, K.; Ihoya, N.; Yoshida, M. Clinical impact of cyclosporine cellular-pharmacodynamics in minimal change nephrotic syndrome. Clin. Pharmacol. Ther. 68:532-540; 2000.
14. Hirano, T.; Oka, K.; Takeuchi, H.; Kozaki, K.; Matsuno, N.; Nagao, T.; Kozaki, M.; Ichikawa, M.; Yoshida, M.; Umezawa, Y.; Hirata, M.; Oh-I, T.; Koga, M. Immuno-suppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis and psoriasis: Possible implications for individual therapeutic efficacy. Clin. Pharmacol. Ther. 62:652-664; 1997.
15. Hirano, T.; Oka, K.; Takeuchi, H.; Sakurai, E.; Matsuno, N.; Tamaki, T.; Kozaki, M. Clinical significance of glucocorticoid pharmacodynamics assessed by anti-lymphocyte action in kidney transplantation: Marked difference between prednisolone and methylprednisolone. Transplantation 57:1341-1348; 1994. (Pubitemid 24145580)
16. Hirano, T.; Oka, K.; Umezawa, Y.; Hirata, M.; Oh-I, T.; Koga, M. Individual pharmacodynamics assessed by anti-lymphocyte action predicts clinical cyclosporine-efficacy in psoriasis. Clin. Pharmacol. Ther. 63:465-470; 1998.
17. Kakumu, S.; Ito, S.; Ishikawa, T.; Mita, Y.; Tagaya, T.; Fukuzawa, Y.; Yoshioka, K. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J. Gastroenterol. Hepatol. 15:431-436; 2000.
18. Kirkham, B. W.; Corkill, M. M.; Davison, S. C.; Panayi, G. S. Response to glucocorticoid treatment in rheumatoid arthritis: In vitro cell mediated immune assay predicts in vivo responses. J. Rheumatol. 18:821-825; 1991.
19. Komolmit, P.; Davies, M. H. Tacrolimus in liver transplantation. Expert Opin. Investig. Drugs 8:1239-1254; 1999.
20. Lakey, J. R.; Kin, T.; Warnock, G. L.; Shapiro, A. M.; Tsapogas, P.; Imes, S.; Korbutt, G. S.; Kneteman, N. M.; Rajotte, R. V.; Ryan, E. A. Long-term graft function after allogeneic islet transplantation. Cell Transplant. 16:441-446; 2007.
21. MacKenjee, M. K.; Kiepiela, P.; Cooper, R.; Coovadia, H. M. Clinically important immunological processes in acute and fulminant hepatitis, mainly due to hepatitis B virus. Arch. Dis. Child. 57:277-282; 1982.
22. McAlister, V. C.; Haddad, E.; Renouf, E.; Malthaner, R. A.; Kjaer, M. S.; Gluud, L. L. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: A meta-analysis. Am. J. Transplant. 6:1578-1585; 2006.
23. Mijiti, A.; Matsuno, N.; Iwahori, T.; Takeuchi, H.; Nagao, T.; Oka, K.; Hirano, T. Increased sensitivities of peripheral-blood mononuclear cells to immunosuppressive drugs in cirrhosis patients awaiting liver transplantation. Cell Transplant. 15:885-891; 2006. (Pubitemid 46174538)
24. Noritomi, T.; Sugawara, Y.; Kaneko, J.; Matsui, Y.; Makuuchi, M. Refractory acute rejection in a living related liver transplantation. Hepatogastroenterology 50: 2192-2193; 2003. (Pubitemid 36958196)
25. O'Grady, J. G.; Hardy, P.; Burroughs, A. K.; Elbourne, D.; UK and Ireland Liver Transplant Study Group. Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: Poststudy surveillance to 3 years. Am. J. Transplant. 7:137-141; 2007.
26. Ono, Y.; Watanabe, T.; Matsumoto, K.; Ito, T.; Kunii, O.; Goldstein, E. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood. J. Infect. Chemother. 10:200-207; 2004.
27. Plosker, G. L.; Foster, R. H. Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 59:324-389; 2000.
28. Ponte, G. M.; Baidal, D. A.; Romanelli, P.; Faradji, R. N.; Poggioli, R.; Cure, P.; Froud, T.; Selvaggi, G.; Pileggi, A.; Ricordi, C.; Alejandro, R. Resolution of severe atopic dermatitis after tacrolimus withdrawal. Cell Transplant. 16:23-30; 2007. (Pubitemid 46516655)
29. Spahn, J. D.; Landwehr, L. P.; Nimmagadda, S.; Surs, W.; Leung, D. Y.; Szefler, S. J. Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma. J. Allergy Clin. Immunol. 98: 1073-1079; 1996.
30. Umezawa, Y.; Oh-I, T.; Koga, M. Relationship between lymphocyte cyclosporin sensitivity and clinical progress of psoriasis. J. Dermatol. Sci. 26:94-99; 2001.
31. Weston, S. J.; Leistikow, R. L.; Reddy, K. R. Reconstitution of hepatitis C virus-specific T-cell mediated immunity after liver transplantation. Hepatology 41:72-81; 2005.